November 15, 2010

An investigative treatment for allergies made by Teva Pharmaceutical Industries appears to work, according to...

November 14, 2010

A drug made by Pfizer may help decrease the risk of cardiovascular death or heart...

November 8, 2010

Two drug makers conducting a late-stage clinical trial of a drug for treating overweight and...

November 8, 2010

Drug maker Upsher-Smith Labs will add an extension study to its late-stage clinical trial of...

November 7, 2010

Patients with rheumatoid arthritis derive about as much benefit from a weekly injection of a...

November 4, 2010

An investigative treatment for hepatitis C got strong results in patients who had failed previous...

November 3, 2010

Nearly 100 drugs are in development for treating Alzheimer’s disease, according to a new report...

November 1, 2010

Amgen's SVP research and development, Joe Miletich, urged members of a Food and Drug Administration...

November 1, 2010

The Food and Drug Administration should ensure patient access, safety and efficacy; create a transparent...

November 1, 2010

A recent study of diabetes information shared on Facebook raised questions about the accuracy of...

October 31, 2010

The U.S. subsidiary of a Swiss biotech company has started a late-stage trial of a...

October 28, 2010

Vivus found itself foiled in its efforts to market a drug for obesity as the...

October 25, 2010

Drug maker Keryx Biopharmaceuticals has finished enrolling participants for a late-stage clinical trial of a...

October 11, 2010

The Food and Drug Administration has turned down an application from a company seeking approval...

October 3, 2010

The Food and Drug Administration turned down a regulatory approval application from Johnson & Johnson...

September 30, 2010

Teva Pharmaceutical Industries and Active Biotech announced promising results from a mid-stage trial of laquinimod,...

September 28, 2010

Keryx has begun its phase-3 clinicial trial of a drug designed to treat elevated serum...

September 26, 2010

An investigational drug made by Johnson & Johnson for treating pain showed significant reduction in...

September 23, 2010

An investigational diabetes drug works as well as a generic already on the market, according...

September 22, 2010

Drug makers Abbott and Reata Pharmaceuticals have signed an agreement concerning a drug for chronic...

September 16, 2010

An advisory committee of the Food and Drug Administration has given a thumbs-down to a...

September 12, 2010

The Food and Drug Administration did not completely withdraw from the market a drug used...

September 8, 2010

British drug maker Shire is working with Cambridge, Mass.-based Acceleron Pharma to develop treatments for...

August 29, 2010

An investigational relapsing multiple sclerosis drug significantly reduced annualized relapse rate in a late-stage clinical...